WEDNESDAY, May 4
8:30 AM - 9:30 AM
RISK MANAGEMENT / FRAUD / FINANCIAL track

Concurrent Session 7.3:
Underwriting Under the Regulatory Microscope

The past several years has seen a marked increase in proposed legislation and regulation as it relates to life insurance underwriting. Issues such as genetic testing, living organ donation, medication use and gender identity have been front and center. More recently, the pandemic has accelerated the industry’s drive for innovation to lower customer touch and faster underwriting decisions. Legislators and regulators have focused their sights on these new processes with concerns over fairness, potential discrimination and privacy. Join this interactive session as panelists identify and breakdown the regulatory aspects of these issues.

Jan Graeber, ASA, MAAA, Senior Actuary ACLI
Bruce Margolis, DO, Assistant Vice President, Chief Medical Director, Pacific Life